Advertisement

Document › Details
Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna.
![]() |
Region | Wien (Vienna) |
Country | Austria | |
![]() |
Organisation | Marinomed Biotech AG (VSE: MARI) |
Organisation 2 | Vienna Stock Exchange (VSE) | |
![]() |
Product | Marinosolv® technology platform |
Product 2 | Carragelose® | |
![]() |
Index term | Marinomed–SEVERAL: investment, 201811–201901 IPO €19.5m+€2.925m with 260k+39k new bearer shares at €75/share |
![]() |
Person | Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO) |
Person 2 | Schmidt, Pascal (Marinomed 201808– CFO before Raymond James Financial + Mummert & Co + Infineon Ventures) | |
Original document
accessed by [iito] on 2018-12-01
Record changed: 2018-12-02 |
Advertisement
![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
More documents for Marinomed Biotech AG (VSE: MARI)
- [1] Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg....
- [2] Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg....
- [3] Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)"....
- [4] Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)"....
- [5] Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)"....
- [6] Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna....
- [7] Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]"....
- [8] Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology"....
- [9] Marinomed Biotech AG. (11/16/18). "Press Release: Marinomed Determines IPO Timeline and Terms [Adhoc-News]"....
- [10] Marinomed Biotech AG. (10/19/18). "Press Release: Initiation of First Marinosolv Clinical Trial (Ph III)"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top